| |
| |
|
| Insider
Information: |
Levy Howard |
| Relationship: |
Chief Medical Officer |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
639 |
|
|
Indirect Shares
|
23,390 |
|
|
| Direct
Value |
$327 |
|
|
|
Indirect Value
|
$11,959 |
|
|
| Total
Shares |
24,029 |
|
|
| Total
Value |
$12,286 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -21.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gyre Therapeutics |
GYRE |
Chief Medical Officer |
2021-08-09 |
639 |
2021-08-09 |
23,390 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GYRE |
Gyre Therapeutics |
Chief Medical Officer |
• – – |
2021-08-09 |
4 |
B |
$3.62 |
$2,313 |
D/D |
639 |
639 |
2.66 |
% |
|
| GYRE |
Gyre Therapeutics |
Chief Medical Officer |
• – – |
2021-02-09 |
4 |
B |
$4.81 |
$8,033 |
I/I |
1,670 |
23,390 |
1.99 |
% |
|
| GYRE |
Gyre Therapeutics |
Chief Medical Officer |
• – – |
2020-08-10 |
4 |
B |
$4.81 |
$8,504 |
D/D |
1,768 |
4,268 |
2.74 |
% |
|
| GYRE |
Gyre Therapeutics |
Chief Medical Officer |
• – – |
2020-03-16 |
4 |
B |
$4.05 |
$10,132 |
D/D |
2,500 |
2,500 |
2.74 |
% |
|
| GYRE |
Gyre Therapeutics |
Chief Medical Officer |
• – – |
2020-02-10 |
4 |
A |
$6.23 |
$8,460 |
D/D |
1,358 |
1,358 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Chief Medical Officer |
• – – |
2019-05-21 |
4 |
GD |
$0.00 |
$0 |
I/I |
16,094 |
16,094 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Chief Medical Officer |
• – – |
2019-05-21 |
4 |
OE |
$4.63 |
$20,372 |
D/D |
4,400 |
16,094 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Chief Medical Officer |
• – – |
2019-02-11 |
4 |
A |
$7.04 |
$17,494 |
D/D |
2,485 |
11,867 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Chief Medical Officer |
• – – |
2019-01-31 |
4 |
OE |
$4.63 |
$6,945 |
D/D |
1,500 |
9,382 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Chief Medical Officer |
• – – |
2018-11-26 |
4 |
OE |
$4.63 |
$690 |
D/D |
149 |
7,709 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Chief Medical Officer |
• – – |
2018-11-16 |
4 |
AS |
$11.00 |
$1,903 |
D/D |
(173) |
7,560 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Chief Medical Officer |
• – – |
2018-11-16 |
4 |
OE |
$4.63 |
$801 |
D/D |
173 |
7,733 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Chief Medical Officer |
• – – |
2018-05-03 |
4 |
OE |
$4.63 |
$35,003 |
D/D |
7,560 |
7,560 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
